NCLT Approves Bajaj Healthcare’s Acquisition of Genrx Pharmaceuticals
Bajaj Healthcare Ltd · Others (Uncategorized) · 14 Oct 2026, 9:52 pm
NCLT Approves Bajaj Healthcare’s Acquisition of Genrx Pharmaceuticals The Hon’ble NCLT, Mumbai Bench, approved Bajaj Healthcare Limited's acquisition of Genrx Pharmaceuticals Private Limited (in Liquidation) on a going concern basis via an order dated 13th Oct'26. The approval follows the company's prior disclosures in Apr'25. Post-implementation of the terms specified in the NCLT order, Genrx Pharmaceuticals will become a wholly owned subsidiary of Bajaj Healthcare. The order became effective immediately on 13th Oct'26, and the company will initiate necessary actions to execute the acquisition in compliance with the NCLT directive.
Original exchange filing (PDF)
More announcements from Bajaj Healthcare Ltd
- Intimation for allotment of 26,710 Equity Shares pursuant to exercise of ESOPs · 18 Nov 2026
- Transcript of Earnings Call for Q2H1FY27 · 27 Oct 2026
- Intimation for Audio Recording of Earnings Call for Q2FY27 · 20 Oct 2026
- Press Release on the financial results of the Company for the quarter ended September 30, 2026 · 18 Oct 2026
- Statement of Deviation & Variation for the quarter ended September 30, 2026 · 17 Oct 2026
- Monitoring Agency Report for the quarter ended September 30, 2026 · 17 Oct 2026
- Financial Results for the quarter ended September 30, 2026 · 17 Oct 2026
- Bajaj Healthcare Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. · 17 Oct 2026
